Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Roche seeks U.S. and E.U. approval for Pegasys in hepatitis B

July 23, 2004

SBIR grant for IBD research at Adenosine Therapeutics and U. of Virginia

July 23, 2004

Phase II results for INKP-102

July 21, 2004

Zelnorm recommended for approval for chronic constipation with restrictions

July 19, 2004

GlaxoSmithKline and Biota hepatitis C collaboration to conclude

July 14, 2004

Selective angiotensin AT2 receptor agonists described by Vicore Pharma

July 13, 2004

European approval for Pariet for Zollinger-Ellison syndrome

July 12, 2004

Antiviral nucleoside derivatives for the treatment of hepatitis C

July 9, 2004

FDA approves new dosing options for Prevacid SoluTab

July 9, 2004

Gastric and intestinal protectants claimed in Altana patent

July 8, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...